Cargando…

Pharmacotherapeutic considerations for chronic pain in chronic kidney and end-stage renal disease

Detalles Bibliográficos
Autores principales:	Mathew, Roy O, Bettinger, Jeffrey J, Wegrzyn, Erica L, Fudin, Jeffrey
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5153274/ https://www.ncbi.nlm.nih.gov/pubmed/27994481 http://dx.doi.org/10.2147/JPR.S125270

Ejemplares similares

OxyContin was submitted and justifiably approved by the agency as a 12-hour dosage form
por: Fudin, Jeffrey, et al.
Publicado: (2016)

Rational dosing of gabapentin and pregabalin in chronic kidney disease
por: Raouf, Mena, et al.
Publicado: (2017)

The Repeal of the Affordable Care Act and Its Likely Impact on Chronic Pain Patients: “Have You No Shame?”
por: Schatman, Michael E, et al.
Publicado: (2020)

Safety concerns with the Centers for Disease Control opioid calculator
por: Fudin, Jeffrey, et al.
Publicado: (2017)

Opioid Taper Practices Among Clinicians
por: Persico, Amelia L, et al.
Publicado: (2021)

Fentalogues
por: Persico, Amelia L, et al.
Publicado: (2020)

Misinterpretation of the “Overdose Crisis” Continues to Fuel Misunderstanding of the Role of Prescription Opioids
por: Bettinger, Jeffrey J, et al.
Publicado: (2022)

Amid COVID-19 crisis, pain therapeutics telehealth services by pharmacist clinicians fill unique void and mitigate risk
por: Bettinger, Jeffrey, et al.
Publicado: (2020)

A Narrative Pharmacological Review of Buprenorphine: A Unique Opioid for the Treatment of Chronic Pain
por: Gudin, Jeffrey, et al.
Publicado: (2020)

Pharmacotherapeutic considerations for use of cannabinoids to relieve pain in patients with malignant diseases
por: Darkovska-Serafimovska, Marija, et al.
Publicado: (2018)

Pharmacogenetic guidance: individualized medicine promotes enhanced pain outcomes
por: Dragic, Lisa Lynn, et al.
Publicado: (2017)

Pharmacotherapeutic management of chronic noncancer pain in primary care: lessons for pharmacists
por: Jouini, Ghaya, et al.
Publicado: (2014)

The Future of Schizophrenia Pharmacotherapeutics: Not So Bleak
por: Carpenter, William T.
Publicado: (2012)

Clinical, Translational and Experimental Pharmacotherapeutics Advances
por: He, Zhiyao, et al.
Publicado: (2023)

End Stage and Chronic Kidney Disease: Associations with Renal Cancer
por: Russo, Paul
Publicado: (2012)

The Effect of Genotyping on the Number of Pharmacotherapeutic Gene–Drug Interventions in Chronic Kidney Disease Patients
por: Kerskes, Catharina H. M., et al.
Publicado: (2023)

Editorial of special issue on pharmacotherapeutics of digestive tumors
por: Fu, Liwu
Publicado: (2020)

The MEDD myth: the impact of pseudoscience on pain research and prescribing-guideline development
por: Fudin, Jeffrey, et al.
Publicado: (2016)

Management of Thrombocytopenia in Chronic Liver Disease: Focus on Pharmacotherapeutic Strategies
por: Maan, Raoel, et al.
Publicado: (2015)

Understanding Buprenorphine for Use in Chronic Pain: Expert Opinion
por: Webster, Lynn, et al.
Publicado: (2020)

Can we not work together to help family practitioners become more effective pain managers?
por: Fudin, Jeffrey, et al.
Publicado: (2016)

Chronic Kidney Disease and the Risk of End-Stage Renal Disease versus Death
por: Dalrymple, Lorien S., et al.
Publicado: (2010)

Preoperative Evaluation in Patients With End-Stage Renal Disease and Chronic Kidney Disease
por: Nasr, Rabih, et al.
Publicado: (2017)

In silico ordinary differential equation/partial differential equation hemodialysis model estimates methadone removal during dialysis
por: Linares, Oscar A, et al.
Publicado: (2015)

Pain in Chronic Medical Illness
por: Brown, Justin, et al.
Publicado: (2013)

Pharmacotherapeutic outcomes in atypical odontalgia: determinants of pain relief
por: Tu, Trang T H, et al.
Publicado: (2019)

An Insight into Potential Pharmacotherapeutic Agents for Painful Diabetic Neuropathy
por: Qureshi, Zunaira, et al.
Publicado: (2022)

Association of Constipation with risk of end-stage renal disease in patients with chronic kidney disease
por: Lu, Chung-Yen, et al.
Publicado: (2019)

Comparison of the Quality of Sleep in Patients With Chronic Kidney Disease and End-Stage Renal Disease
por: Mujahid, Mehreen, et al.
Publicado: (2022)

The importance of accurate measurement of aortic stiffness in patients with chronic kidney disease and end-stage renal disease
por: Adenwalla, Sherna F., et al.
Publicado: (2017)

Chronic inflammation in end-stage renal disease and dialysis
por: Cobo, Gabriela, et al.
Publicado: (2018)

A Randomized, Crossover, Pharmacokinetic and Adhesion Performance Study of a Lidocaine Topical System 1.8% During Physical Activity and Heat Treatment in Healthy Subjects
por: Fudin, Jeffrey, et al.
Publicado: (2020)

Uremic and Post-Transplant Gastropathy in Patients With Chronic Kidney Disease and End-Stage Renal Disease
por: Turshudzhyan, Alla, et al.
Publicado: (2020)

Serum Endocan Levels and Subclinical Atherosclerosis in Patients with Chronic Kidney and End-Stage Renal Diseases
por: El-Senosy, Fatma M., et al.
Publicado: (2022)

The United States Drug Enforcement Administration and Prescription Opioid Production Quotas: An End Game of Eradication?
por: Schatman, Michael E, et al.
Publicado: (2020)

A systematic review of pharmacotherapeutic clinical trial end-points for bronchiectasis in adults
por: Crichton, Megan L., et al.
Publicado: (2019)

The damage done by the war on opioids: the pendulum has swung too far
por: Atkinson, Timothy J, et al.
Publicado: (2014)

Fact or fiction: the truth behind the doctors company claims regarding licit and illicit opioids
por: Dragic, Lisa Lynn, et al.
Publicado: (2018)

United States Renal Data System public health surveillance of chronic kidney disease and end-stage renal disease
por: Collins, Allan J, et al.
Publicado: (2015)

Pharmacotherapeutic targets in Alzheimer's disease
por: Biran, Yif'at, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_t77gnlup0g52ifbu9klr8l3l52